2nd Quarter - Report

CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

340B drug discount program; drug pricing; importation of biopharmaceuticals; transparency; direct-to-consumer (DTC) advertising; international pharmaceutical supply chain; education around COVID-19 therapies; antimicrobial resistance legislation; PDUFA Reauthorization; S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; S.3799, PREVENT Pandemics Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022. DoD TRICARE Pharmacy Benefits Program; FY2023 National Defense Authorization Act (H.R.7900), S.4293, Pharmacy Benefit Manager Transparency Act of 2022. Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22) and SUPPORT for Patients and Communities Act (P.L.115-271). Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act (draft legislation).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4348 (117th), S. 909 (117th), S. 3799 (117th), S. 908 (117th), S. 4293 (117th), S. 920 (117th), H.R. 7900 (117th), H.R. 7667 (117th)

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; noninterference; Center for Medicare and Medicaid Innovation (CMMI); drug pricing; Valued-Based Payments; Proposed Part B IPI Demonstration Project; Medicaid rebates and AMP Cap; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; FY2022 Budget Reconciliation (H.R.5376); S.2428, False Claims Amendments Act of 2021.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1868 (117th), S. 2428 (117th), H.R. 3 (117th), H.R. 5376 (117th), H.R. 1319 (117th)

Budget/Appropriations BUD

Provisions related to supplemental appropriations and federal health programs; H.R.748, CARES Act (P.L.116-136) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 748 (117th), H.R. 1319 (117th)

Copyright/Patent/Trademark CPT

Biopharmaceutical innovation and patent policy issues. Trademark legislative proposals. Bayh-Dole march-in rights policy issues.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Issues related to pharmaceutical IP and supply chain; S.1260, United States Innovation and Competition Act of 2021; H.R.4521, America COMPETES Act of 2022.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1260 (117th), H.R. 4521 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.